<DOC>
	<DOCNO>NCT00753623</DOCNO>
	<brief_summary>This proposal conduct double-blinded , randomize , placebo-controlled , crossover clinical study examine hypothesis ramelteon would reduce pain score improve functional status subject neuropathic pain .</brief_summary>
	<brief_title>Clinical Management Neuropathic Pain With Ramelteon</brief_title>
	<detailed_description>Neuropathic pain chronic pain condition result injury peripheral and/or central nervous system . Despite extensive research last several decade , neuropathic pain remain poorly manage due lack effective pharmacological tool . To date , little known regard effect melatonin analogues clinical neuropathic pain . We propose conduct randomize , placebo-controlled , double-blinded , crossover clinical trial examine effect ramelteon [ melatonin ( MT ) 1/ MT2 receptor agonist ] neuropathic pain . We hypothesize ramelteon would reduce pain score improve functional status subject neuropathic pain .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>1 . Subject age 18 65 year . 2 . Subject ramelteon least one month . 3 . Subject agrees make change his/her current pain medication entire study period ( 5 week ) . This requirement ensure valid comparison primary secondary measure make study . 4 . Subject VAS pain score 5 begin study . 5 . Subject neuropathic pain condition list least three month . This requirement avoid clinical uncertainty unstable pain condition minimize study variation . 6 . Female subject childbearing potential must negative urine pregnancy test initial visit . 1 . Subject moderate severe liver impairment . 2 . Subject Liver Function Tests ( LFT 's ) &gt; 1.5X normal . 3 . Subject history renal impairment . 4 . Subject moderate severe cardiac pulmonary disease include base line oxygen saturation le 95 % room air requirement supplemental oxygen . 5 . Subject history glaucoma . 6 . Subject obstructive sleep apnea . 7 . Subject take medication sleep disorder include insomnia . 8 . Subject major psychiatric disorder ( major depression require recent hospitalization within three month prior study ; bipolar disorder ; schizophrenia ; psychotic disorder ; substance abuse ) . 9 . Subject history dementia delirium . 10 . Subject history fall . 11 . Subject pregnant lactating . 12 . Subject use illicit drug detect screening test . 13 . Subject currently take Fluvoxamine . 14 . Subject take Ketoconazole past two week . 15 . Subject know hypersensitivity ramelteon . 16 . Subject pending litigation relate his/her neuropathic pain condition . 17 . Subject Concurrent participation research drug trial study participation within 30 day enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>Pain score</keyword>
</DOC>